Viral Hepatitis News

As experts raise awareness of the evidence supporting shorter antibiotic therapy for some conditions and the benefits of oral vs. IV-only therapy for others, we wanted to know: What is another ID dogma that should be reevaluated?

I think it was in 1965 — so, a long time ago — that I finished my internship in the U.K. and wanted to do something a little bit more interesting than staying on the usual rotation through jobs.

For the latest story in our “Life during COVID” series, we asked experts to describe the impact the pandemic has had on patient health and the practice of medicine in the United States.

People who were not responsive to hepatitis B vaccination should be considered for revaccination following hepatitis C cure, researchers reported.

A nationally representative survey revealed that of the more than 2 million people with current hepatitis C virus infection, only 68% are aware of their infection.

In new guidance, the CDC recommended that the two-step testing process for hepatitis C virus be completed in one visit, eliminating the need for multiple visits, which often leads to incomplete testing.

An analysis of data from 2013 to 2022 showed that only 34% of people diagnosed with hepatitis C in the United States were cured or cleared of the virus, with many still lacking access to highly effective treatments.

Women who reported having health insurance were significantly more likely to initiate hepatitis C treatment vs. women without health insurance, according to a study published in Clinical Infectious Diseases.

A dried blood spot test can be used to detect HIV, hepatitis B and hepatitis C in a single drop of blood, researchers reported at the European Congress of Clinical Microbiology & Infectious Diseases.

Being prescribed a 90-day or a “mixed duration” supply of entecavir or tenofovir disoproxil fumarate was associated with higher fill rates among commercially insured patients with chronic hepatitis B, researchers found.